Vita Life Sciences (VLS.AX) Earnings Analysis
Vita Life Sciences (VLS.AX) has no confirmed upcoming earnings date. Trailing P/E 13.55.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VLS.AX next report earnings?
No confirmed upcoming earnings date is currently scheduled for VLS.AX. This page updates as the calendar is published.
VLS.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-22 | 0.1 AUD | n/a | n/a | n/a |
| 2025-08-25 | 0.08605 AUD | n/a | n/a | n/a |
| 2025-02-24 | 0.08159 AUD | n/a | n/a | n/a |
VLS.AX valuation and analyst view
| Trailing P/E | 13.55 |
|---|---|
| Trailing EPS | 0.18706 AUD |
| Price / book | 2.50 |
| Dividend yield | 5.56% |
| Market cap | 0.14B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Vita Life Sciences (VLS.AX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for VLS.AX. This page updates as the calendar is published.
Did VLS.AX beat earnings last quarter?
Consensus estimate data was not available for VLS.AX's 2026-02-22 report.
What is VLS.AX's current P/E ratio and EPS?
VLS.AX trades at a trailing P/E of 13.55 on trailing EPS of 0.18706415933169604 AUD.
What do analysts rate VLS.AX?
VLS.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.